HBV Citations List: January 2023
Literature Citations
1. Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection. Burdette, D., A. Hyrina, Z. Song, R.K. Beran, T. Cheung, S. Gilmore, T. Kobayashi, L. Li, Y. Liu, A. Niedziela-Majka, J. Medley, U. Mehra, P. Morganelli, N. Novikov, C. Niu, D. Tam, J. Tang, J. Wang, Q. Yue, S.P. Fletcher, M.M. Holdorf, W.E.t. Delaney, B. Feierbach, and S. Lazerwith. Antimicrobial Agents and Chemotherapy, 2023. 67(1): e0134822. PMID[36519892]. PMCID[PMC9872672].
[PubMed]. HBV_01_2023.
2. Ciliatoside A, Isolated from Peristrophe japonica, Inhibits HBsAg Expression and cccDNA Transcription by Inducing Autophagy. Fang, R., T. Ming, J.P.L. Ng, W. An Guo, Y. Si Yu, Z. Hui, R. Ji Hua, C. Sheng Tao, Z. Juan, L. Hang Hong, V.K.W. Wong, B.Y.K. Law, and C. Juan. Antiviral Research, 2023. 209: 105482. PMID[36496141].
[PubMed]. HBV_01_2023.
3. Combination Treatment with HBV-targeting GalNAc-siRNA and Small-molecule PD-L1 Inhibitor Increases HBV-specific Immune Responses in a Chronic Hepatitis B Infection Mouse Model. Thi, E.P., I. Graves, A. Mondal, A.G. Cole, G. Heffernan, C.L. Iott, S. Ozturk, S.C. Ganchua, D. Nguyen, K. Stever, K. Fan, J.G. Quintero, S.G. Kultgen, A. Pohl, T. Harasym, A.M. Lam, and M.J. Sofia. Hepatology, 2022. 76: p. S327-S327. ISI[000870796601045].
[WOS]. HBV_01_2023.
4. Alpha-Kinase 1 (ALPK1) Agonist DF-006 Demonstrates Potent Efficacy in Mouse and Primary Human Hepatocyte (PHH) Models of Hepatitis B. Xu, C., J. Fan, D. Liu, A. Tuerdi, J. Chen, Y. Wei, Y. Pan, H. Dang, X. Wei, A.S. Yousif, J. Yogaratnam, Q. Zhou, H. Lichenstein, and T. Xu. Hepatology, 2023. 77(1): p. 275-289. PMID[35699669].
[PubMed]. HBV_01_2023.
5. Preclinical Characterization of ABI-H2158, an HBV Core Inhibitor with Dual Mechanisms of Action. Yan, R., D. Cai, Y. Zong, L. Guo, Y. Zhou, A. Tang, L. Li, Q. Huang, R. Colonno, and M.A. Walker. Antiviral Research, 2023. 209: 105485. PMID[36509208].
[PubMed]. HBV_01_2023.
6. Protective Effects of Clinacanthus nutans (Burm.f.) Lindau Aqueous Extract on HBV Mouse Model by Modulating Gut Microbiota and Liver Metabolomics. Zhang, R., Z. Lu, Y. Xu, Q. Peng, M. Xiao, and S. Sang. Evidence-based Complementary and Alternative Medicine, 2023. 2023: 5625222. PMID[36636608]. PMCID[PMC9831714].
[PubMed]. HBV_01_2023.
Patent Citations
This month, no relevant HBV patents were identified.